Try it
Ophthalmology · Uvea: dexamethasone implant
Sample itemA pseudophakic patient has persistent uveitic macular oedema despite topical therapy, and repeated systemic steroids are poorly tolerated. Which local option can be used?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Intravitreal sustained-release dexamethasone implant
A biodegradable intravitreal dexamethasone implant delivers steroid to the macula for months and reduces uveitic macular oedema. Caution is needed for raised IOP, and cataract in phakic eyes. Antibiotics, laser and cycloplegics do not treat inflammatory oedema.
Option by option
A. Topical atropine drops
Atropine relieves ciliary spasm and does not resolve macular oedema.
B. Intravitreal gentamicin
Intravitreal gentamicin is toxic to the retina and not an anti-inflammatory.
C. Intravitreal sustained-release dexamethasone implant (correct)
Correct. Local sustained steroid reduces macular oedema with fewer systemic effects.
D. Panretinal photocoagulation
Panretinal photocoagulation treats ischaemia, not inflammatory macular oedema.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Ophthalmology questions
- GlaucomaWhich topical glaucoma medicine lowers intraocular pressure mainly by increasing uveoscl…
- Ocular oncologyA 2-year-old child has a white pupillary reflex (leukocoria). The gene commonly involved…
- UveaA patient has a painful red eye with photophobia, ciliary congestion, a small irregular…
- GlaucomaWhich drug is given systemically to reduce intraocular pressure in acute angle-closure g…